Carnegie Investment Counsel’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-2,290
| Closed | -$227K | – | 443 |
|
2019
Q3 | $227K | Buy |
2,290
+120
| +6% | +$11.9K | 0.01% | 394 |
|
2019
Q2 | $201K | Sell |
2,170
-1,900
| -47% | -$176K | 0.01% | 414 |
|
2019
Q1 | $384K | Sell |
4,070
-4,104
| -50% | -$387K | 0.03% | 330 |
|
2018
Q4 | $524K | Buy |
8,174
+2,170
| +36% | +$139K | 0.05% | 252 |
|
2018
Q3 | $417K | Sell |
6,004
-4,528
| -43% | -$314K | 0.03% | 258 |
|
2018
Q2 | $976K | Sell |
10,532
-17
| -0.2% | -$1.58K | 0.07% | 206 |
|
2018
Q1 | $892K | Sell |
10,549
-728
| -6% | -$61.6K | 0.07% | 198 |
|
2017
Q4 | $1.07M | Sell |
11,277
-293
| -3% | -$27.9K | 0.1% | 207 |
|
2017
Q3 | $1.41M | Buy |
11,570
+254
| +2% | +$31K | 0.17% | 156 |
|
2017
Q2 | $1.53M | Hold |
11,316
| – | – | 0.19% | 138 |
|
2017
Q1 | $1.35M | Buy |
11,316
+1,450
| +15% | +$173K | 0.17% | 142 |
|
2016
Q4 | $1.17M | Sell |
9,866
-222
| -2% | -$26.3K | 0.16% | 146 |
|
2016
Q3 | $1.01M | Buy |
10,088
+200
| +2% | +$19.9K | 0.15% | 150 |
|
2016
Q2 | $1.06M | Buy |
9,888
+575
| +6% | +$61.9K | 0.15% | 154 |
|
2016
Q1 | $932K | Buy |
9,313
+375
| +4% | +$37.5K | 0.14% | 164 |
|
2015
Q4 | $890K | Buy |
8,938
+2,260
| +34% | +$225K | 0.15% | 154 |
|
2015
Q3 | $840K | Buy |
6,678
+4,795
| +255% | +$603K | 0.14% | 155 |
|
2015
Q2 | $218K | Sell |
1,883
-542
| -22% | -$62.7K | 0.04% | 269 |
|
2015
Q1 | $281K | Buy |
2,425
+192
| +9% | +$22.2K | 0.05% | 249 |
|
2014
Q4 | $257K | Sell |
2,233
-199
| -8% | -$22.9K | 0.05% | 244 |
|
2014
Q3 | $231K | Buy |
+2,432
| New | +$231K | 0.05% | 265 |
|